Ann: Investor Presentation, page-6

A lot to unpack in the various announcements. FY24 Q2 is going to be big in terms of the future of SPA. PURE are aggressive and clearly having a big say internally as well as becoming a significant SH through the Warrants. 2025 cannot come quickly enough to remove PURE as a controlling interest in SPA. The old story "the man who controls the cash is the king".

On the positive side the turnaround story is progressing well but had to burn quite a bit of cash from the $0.03 CR. The Board is supporting the new CR at $0.022 but obviously not confident enough to keep the $0.03 valuation in place which is disappointing particularly when compared to Life360 valuation. SHs can rightly feel frustrated as the continuing dilution is a negative on SP. DYOR